These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18789710)

  • 61. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Laser desorption Fourier transform ion cyclotron resonance mass spectrometry vs. fast atom bombardment magnetic sector mass spectrometry for drug analysis.
    Shomo RE; Marshall AG; Weisenberger CR
    Anal Chem; 1985 Dec; 57(14):2940-4. PubMed ID: 4083491
    [No Abstract]   [Full Text] [Related]  

  • 63. Frontiers in biological mass spectrometry.
    Brancia FL
    Comb Chem High Throughput Screen; 2009 Feb; 12(2):124. PubMed ID: 19199881
    [No Abstract]   [Full Text] [Related]  

  • 64. Infrared multiphoton dissociation in quadrupole ion traps.
    Brodbelt JS; Wilson JJ
    Mass Spectrom Rev; 2009; 28(3):390-424. PubMed ID: 19294735
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of selected-ion flow-tube mass spectrometry for the measurement of ethanol, methanol and isopropanol in physiological fluids: effect of osmolality and sample volume.
    Rowbottom L; Workman C; Roberts NB
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2763-7. PubMed ID: 19639584
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
    Mallett DN; Ramírez-Molina C
    J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Separation and sample pre-treatment in bioanalysis using monolithic phases: A review.
    Saunders KC; Ghanem A; Boon Hon W; Hilder EF; Haddad PR
    Anal Chim Acta; 2009 Oct; 652(1-2):22-31. PubMed ID: 19786168
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sample preparation development and matrix effects evaluation for multianalyte determination in urine.
    Marchi I; Rudaz S; Veuthey JL
    J Pharm Biomed Anal; 2009 Feb; 49(2):459-67. PubMed ID: 19157744
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thermal desorption counter-flow introduction atmospheric pressure chemical ionization for direct mass spectrometry of ecstasy tablets.
    Inoue H; Hashimoto H; Watanabe S; Iwata YT; Kanamori T; Miyaguchi H; Tsujikawa K; Kuwayama K; Tachi N; Uetake N
    J Mass Spectrom; 2009 Sep; 44(9):1300-7. PubMed ID: 19565470
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Suitability of tetrahydofuran as a dopant and the comparison to other existing dopants in dopant-assisted atmospheric pressure photoionization mass spectrometry in support of drug discovery.
    Cai Y; McConnell O; Bach AC
    Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2283-91. PubMed ID: 19575400
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The best model for humans is human -- how to accelerate early drug development safely.
    Seymour M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():61-5. PubMed ID: 19807205
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
    He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
    Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sizing Up Protein-Ligand Complexes: The Rise of Structural Mass Spectrometry Approaches in the Pharmaceutical Sciences.
    Eschweiler JD; Kerr R; Rabuck-Gibbons J; Ruotolo BT
    Annu Rev Anal Chem (Palo Alto Calif); 2017 Jun; 10(1):25-44. PubMed ID: 28301749
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Accelerating clinical insights: how to use accelerator mass spectrometry to make better early development decisions.
    Seymour M
    Altern Lab Anim; 2010 Dec; 38 Suppl 1():15-20. PubMed ID: 21275478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Accelerator mass spectrometry for quantitative in vivo tracing.
    Vogel JS
    Biotechniques; 2005 Jun; Suppl():25-9. PubMed ID: 16528913
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuroscience and accelerator mass spectrometry.
    Palmblad M; Buchholz BA; Hillegonds DJ; Vogel JS
    J Mass Spectrom; 2005 Feb; 40(2):154-9. PubMed ID: 15706618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.
    Gibson CR; Bergman A; Lu P; Kesisoglou F; Denney WS; Mulrooney E
    Xenobiotica; 2009 Sep; 39(9):637-48. PubMed ID: 19480559
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Imaging of nutrient elements in the leaves of Elsholtzia splendens by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).
    Wu B; Zoriy M; Chen Y; Becker JS
    Talanta; 2009 Apr; 78(1):132-7. PubMed ID: 19174215
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stopping powers of a tissue-equivalent gas for 40--200 keV protons.
    Fukuda A
    Phys Med Biol; 1980 Sep; 25(5):877-86. PubMed ID: 6256781
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Study of the factors affecting the performance of microextraction by packed sorbent (MEPS) using liquid scintillation counter and liquid chromatography-tandem mass spectrometry.
    Altun Z; Abdel-Rehim M
    Anal Chim Acta; 2008 Dec; 630(2):116-23. PubMed ID: 19012822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.